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Objectives. We sought to assess smooth muscle function in
adults at risk for atherosclerosis.
Background. Previous studies in subjects at risk for atheroscle-
rosis have demonstrated arterial endothelial dysfunction, with
reduced vasodilator responses after pharmacologic or physiologic
stimulation of endothelial nitric oxide (NO). Most have also
shown a slight but nonsignificant impairment of vasodilation in
response to exogenous sources of NO, such as nitroglycerin
(NTG). We hypothesized that NTG responses might be reduced in
a large number of consecutively studied adults at risk for athero-
sclerosis, independent of any impaired endothelium-dependent
responses, consistent with concomitant smooth muscle dysfunc-
tion.
Methods. Using high resolution ultrasound, the dilator re-
sponse of the brachial artery to 400 mg of sublingual NTG was
measured in 800 asymptomatic subjects. Subjects were also
assessed for a history of vascular risk factors, blood pressure,
total serum cholesterol and flow-mediated endothelium-
dependent dilation (EDD).
Results. We studied 317 men and 483 women, 38 6 17 years old
(mean 6 SD, range 15 to 76). The mean cholesterol level was 5.2 6
1.3 mmol/liter, and there were 126 smokers and ex-smokers (16 6
9 mean pack-years) and 105 diabetic subjects. On univariate
analysis, a reduced vasodilator response to NTG was associated
with high cholesterol, cigarette smoking, diabetes mellitus, in-
creasing age, male gender, larger vessel size and reduced EDD (p
<2 0.01 for all). On multivariate analysis, diabetes, larger vessel
size and reduced EDD were all independently associated with
impaired NTG-related vasodilation (p <2 0.001 for all). In the 574
nondiabetic subjects who had never smoked cigarettes, the inde-
pendent relation between EDD and NTG responses was still
observed (r 5 0.24, p 5 0.01).
Conclusions. The vasodilator response to exogenous NO is
impaired in asymptomatic subjects with reduced EDD, consistent
with smooth muscle dysfunction in adults at risk for atheroscle-
rosis.
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Over the past decade, a large number of studies have demon-
strated endothelial dysfunction in the coronary arteries of
adults with established atherosclerosis (1–7) and even in the
plaque-free peripheral arteries of asymptomatic children and
young adults at high risk for atherosclerosis (8–11). These
studies have documented an impaired dilator response to
physiologic and pharmacologic stimuli of endothelial nitric
oxide (NO) production (such as shear stress or acetylcholine
infusion), in contrast to a preserved dilator response to exog-
enous sources of NO, such as nitroglycerin (NTG), which act as
endothelium-independent, smooth muscle dependent dilators.
Observers have concluded from these findings that there is
impaired endothelial function early in the process of athero-
genesis but that smooth muscle function remains normal (8,9).
However, in most of these relatively small studies the NTG
responses have actually been mildly reduced in those subjects
with endothelial dysfunction, although this observation has not
been statistically significant (1–3,6–12).
These in vivo observations in humans with endothelial
dysfunction contrast sharply with in vitro and experimental
animal data, where vasodilator responses of healthy vessels to
exogenous NO are increased after endothelial denudation or
acute inhibition of endothelial NO synthesis (13–16). It has
been postulated (13) that this experimental effect may be due
to upregulation of receptors in smooth muscle cells or to a loss
of partial tolerance induced by the effect of endogenously
produced NO from an intact endothelium. However, the
relevance of these findings in humans is uncertain because the
same pathologic processes that lead to endothelial dysfunction
in adults (such as hypercholesterolemia or smoking) may also
be affecting smooth muscle function.
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To assess the interactions between atherosclerotic risk
factors, endothelial function and smooth muscle-dependent
dilation in humans, we investigated the vasodilator responses
to endogenous and exogenous sources of NO. Vascular re-
sponses were examined in a large number of consecutively
studied asymptomatic subjects, in a systemic artery without
evidence of atherosclerotic plaque formation.
Methods
Subjects. Subjects were eligible for inclusion in the study if
they were #15 years old, had no clinical evidence of athero-
sclerotic vascular disease, had not taken any vasoactive medi-
cation in the past 6 months and consented to measurement of
flow-mediated and NTG-induced vasodilation of their brachial
artery. Between 1993 and 1997, the same operator (J.R.) used
the same ultrasound equipment and methodology (see later) to
scan 800 consecutive subjects who fulfilled the above criteria;
many of these subjects have contributed to previous reports of
endothelial function from our groups (8,10,11,17). All were
recruited from among hospital staff, friends and community
volunteers, to participate in studies examining the effects of
risk factors on aspects of arterial physiology. The studies were
all approved by the local institutional ethics committee, and
each subject gave informed consent.
Study design. All subjects were asked for details of their
medical history, particularly for cardiovascular risk factors, and
underwent a brief examination for clinical features of cardio-
vascular disease. In 747 subjects (93%), total serum cholesterol
was also measured using either a Hitachi 747 autoanalyzer or
the cholesterol C-system high performance CHOD-PAP
method (Diagnostica, Boehringer Mannheim GmbH, Mann-
heim, Germany). All subjects had their blood pressure mea-
sured after at least 10 min of supine rest.
Brachial artery vascular reactivity. High resolution exter-
nal ultrasound (128XP/10 mainframe with a 7.0-MHz linear
array transducer, Acuson) was used to measure changes in
brachial artery diameter in response to reactive hyperemia
(leading to flow-mediated endothelium-dependent dilation
[EDD]) and in response to 400 mg of sublingual nitroglycerin
(NTG), an endothelium-independent, direct smooth-muscle
dilator (8). The right brachial artery was scanned in longitudi-
nal sections 2 to 15 cm above the elbow (control scan), after at
least 10 min of rest in the supine position. Depth and gain
settings were optimized to identify the vessel wall/lumen
interface, and a baseline scan was recorded. Hyperemia was
induced by inflation and then deflation of a pneumatic cuff
placed around the forearm (below the scanned part of the
artery) and inflated to ;250 mm Hg for 4.5 min. The artery
was scanned before cuff inflation and for 90 s after cuff
deflation. After at least 10 min rest, a further control scan was
recorded. A single 400-mg metered dose of NTG (Nitrolingual
spray, Fisons) was then administered sublingually by one of the
investigators, in a standardized manner, and a final scan was
recorded. All scans were recorded on super-VHS tape and
later analyzed by two independent observers blinded to the
identity of the subject, the scan sequence and the stage of the
experiment. Each observer analyzed the arterial diameter for
four cardiac cycles for each condition, and these measurements
were averaged. Diameter measurements were taken at end-
diastole, coincident with the R wave on a continuously re-
corded electrocardiographic trace. For calculation of EDD,
the vessel diameter at 50 to 60 s after cuff deflation was divided
by the average control diameter. NTG-induced dilation was
calculated as the vessel diameter at 3 min after NTG admin-
istration divided by the average control diameter. For each
subject, the average value of the two observers for both EDD
and NTG-induced dilation is presented.
Statistics. Data were analyzed using SPSS for Windows
6.0. All descriptive data are expressed as mean value 6 SD.
Univariate and multivariate analyses of associations were
assessed using standard linear regression techniques, with
NTG response as the dependent variable. Of the independent
variables, EDD, total cholesterol, age, cigarette smoking
(pack-years) and vessel size were treated as continuous vari-
ables, and gender and diabetes mellitus were treated as
categoric variables. Statistical significance was inferred at p ,
0.05.
Results
Subjects. There were 800 subjects with a mean age of 38 6
16 years (range 15 to 76). There were 317 men (40%) and 483
women (60%). There was a history of current smoking in 84
subjects (10.5%), and 40 were ex-smokers (5.0%). In those
subjects with a history of current or previous smoking, the
mean lifetime smoking dose was 16 6 9 pack-years. There were
105 subjects with diabetes mellitus (13.1%) (102 with insulin-
dependent diabetes mellitus, 3 with non–insulin-dependent
diabetes mellitus). Mean total cholesterol in the group was
5.2 6 1.3 mmol/liter (range 2.8 to 14.2). No subject had a
history of hypertension; mean blood pressure was 122/79 6
18/15 mm Hg. No subject had documented coronary artery
disease, and none had clinical evidence of either coronary or
peripheral arterial insufficiency. The ultrasound assessment of
vascular reactivity was well tolerated in all subjects, none of
whom had evidence of brachial artery atherosclerotic plaque
on ultrasound scanning.
Vasodilator response to NTG. Mean NTG-induced arterial
dilation in all subjects was 17.5 6 6.0% (range 4.3% to 42%).
On univariate analysis, a reduced NTG response was signifi-
cantly correlated with a number of traditional risk factors for
coronary artery disease, such as male gender, increasing age,
Abbreviations and Acronyms
EDD 5 endothelium-dependent dilation
GMP 5 guanosine monophosphate
NO 5 nitric oxide
NTG 5 nitroglycerin
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increasing total cholesterol and a history of cigarette smoking
or diabetes mellitus (Table 1). In addition, there was a
significant correlation between the vessel diameter and the
percent dilation in response to NTG (r 5 20.52, p , 0.001).
When subjects with diabetes or a history of smoking were
excluded, the remaining 574 subjects still demonstrated a
significant relation between the response to NTG and age (r 5
20.09, p 5 0.009), total serum cholesterol (r 5 20.15, p ,
0.001), male gender (r 5 20.26, p , 0.001) and vessel size (r 5
20.52, p , 0.001) on univariate analysis. On multivariate
analysis of the entire cohort (Table 2), the independent
predictors of a reduced NTG response included larger vessel
size and the presence of diabetes mellitus (consistent with our
previous observations [17] in a smaller cohort of diabetic
subjects).
EDD. The mean value for EDD in all subjects was 6.0 6
3.7% (range 23.0% to 17.2%). On univariate analysis, reduced
EDD was significantly associated with a history of diabetes
(r 5 20.08, p 5 0.03), cigarette smoking (r 5 20.14, p ,
0.001), increasing total serum cholesterol (r 5 20.21, p ,
0.001), increasing age (r 5 2 0.25, p , 0.001) and larger vessel
size (r 5 20.38, p , 0.001), consistent with our previous
findings (8,11).
Response to NTG and endothelial function. Across the
entire group of 800 subjects, EDD and NTG responses were
significantly correlated (r 5 0.41, p , 0.001) (Fig. 1). This
correlation remained highly significant on multivariate analy-
sis, independent of the effects of vascular risk factors or vessel
size (p , 0.01) (Table 2). Similar results were obtained when
male and female subjects were examined separately. This
relation between NTG response and EDD was also present in
a multivariate model in which only those asymptomatic sub-
jects without diabetes or a history of smoking were considered
(r 5 0.24, p , 0.001).
Discussion
In this study of 800 asymptomatic subjects undergoing
assessment of vascular reactivity of the brachial artery, there
was a significant relation between the arterial dilator response
to NTG and EDD, independent of the effects of vessel size or
traditional vascular risk factors. These data demonstrate that
the arterial smooth muscle response to exogenous NO is
impaired in humans with risk factors for atherosclerosis. Such
observations are consistent with the trend toward impaired
arterial responses to NTG documented in previous smaller
series in humans (e.g., 1–3,6–12), in which the impairment of
endothelial function was much greater than that of the smooth
muscle dilator response. Only one previous study has specifi-
cally examined the NTG dilator response in relation to endo-
thelial dysfunction. In a smaller series of 110 patients under-
going coronary angiography for chest pain syndromes,
Anderson et al. (12) found that NTG-induced vasorelaxation
was slightly but not significantly lower in subjects with constric-
tor than in those with dilator responses to infused acetylcho-
line. The present study addresses this relation in a larger
cohort of asymptomatic subjects and confirms a significant
impairment of the NTG response in those adults with reduced
EDD.
NTG and smooth muscle function. An impaired dilator
response to NTG may be due to decreased bioavailability of
NTG/NO to the smooth muscle cell, to mechanical forces
limiting the artery’s ability to relax or to actual smooth muscle
cell dysfunction. For the first possibility, it is well documented
that certain vascular risk factors (e.g., hypercholesterolemia)
Table 1. Univariate Correlations Between Cardiovascular Risk
Factors and Vasodilator Response to Nitroglycerin in All
800 Subjects
Variable
Regression
Coefficient p Value
EDD 0.41 , 0.001
Total cholesterol 20.15 , 0.001
Age 20.09 , 0.01
Cigarette smoking (pack-yr) 20.10 , 0.001
Diabetes mellitus 20.15 , 0.001
Male gender 20.26 , 0.001
Vessel size 20.52 , 0.001
EDD 5 endothelium-dependent dilation.
Table 2. Multivariate Model for Vasodilator Response to
Nitroglycerin in All 800 Subjects*
Variable
Regression
Coefficient p Value
Diabetes 20.11 , 0.001
Male gender 0.002 0.96
Age 20.017 0.60
Cigarette smoking (pack-yr) 20.009 0.78
Vessel size 20.43 , 0.001
EDD 0.24 , 0.001
*Multiple r 5 0.60, F 5 51.7, p , 0.001. EDD 5 endothelium-dependent
dilation.
Figure 1. Scatterplot showing the significant relation between reduced
EDD and reduced response to nitroglycerin (NTG). In this series of
800 subjects, the statistically significant relation between EDD and the
vasodilator response to NTG is observed independently of the effects
of vessel size or traditional vascular risk factors (see Results).
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are associated with overproduction of oxygen-derived free
radicals in the vessel wall (18–20); these may combine with
endothelial derived NO, forming peroxynitrite, and thereby
decreasing the bioavailability of NO to the smooth muscle cell,
contributing to impaired EDD. However, this effect is unlikely
to be relevant to the dilator activity of NTG because NTG
activity depends on its conversion to NO inside the smooth
muscle cells (21) and the subsequent activation of guanylate
cyclase, the accumulation of cyclic guanosine monophosphate
(GMP) and thus vasorelaxation. Previous arterial studies
showing a trend toward decreased NTG responses at the site of
coronary stenoses (1–3) may have been confounded by the
mechanical inability of a vessel to dilate at the site of a discrete
plaque. However, in the current study the NTG response was
assessed in an artery without discrete plaques, minimizing the
possibility that gross structural changes could explain the
observed impairment of NTG responses in the adults with
endothelial dysfunction.
These findings therefore suggest that, early in the process of
atherosclerosis, changes in the vessel wall may not be limited to
the endothelium and that the reduction in vasodilation in
response to both endothelium-derived and exogenous sources
of NO may be mediated (in part) by changes in vascular
smooth muscle. The mechanism underlying this change in
vasodilator capacity is not clear. Scha¨chinger and Zeiher (22)
have suggested that a reduced vasodilator response may be
related to changes in baseline vasomotor tone in the presence
of atherosclerosis; however, it is not known whether this might
be the case in vessels that are structurally normal. It is also
possible that microscopic structural changes, such as early
fibrosis or smooth muscle atrophy, may exist in the vessel wall
long before there are structural changes, such as plaques
detectable by ultrasound (23). Functional changes may also
exist in the vascular smooth muscle to account for the altered
reactivity to NTG, such as decreased activity of intracellular
guanylate cyclase, cyclic GMP or calcium-dependent relax-
ation.
Endothelial function and response to NTG. Several inves-
tigators previously examined the influence of the endothelium
on NO-related vasodilation using in vitro studies and experi-
mental models of atherosclerosis. Pohl and Busse (15) exam-
ined the vasodilator effects of sodium nitroprusside on rabbit
thoracic aorta and femoral artery. They demonstrated that in
the femoral artery, but not in the aorta, the absence of an
intact endothelium, or blockade of endothelial nitric oxide
synthase, resulted in an enhanced vasodilatory response to
sodium nitroprusside. The mechanism of this effect was further
investigated by Moncada et al. (13) who found that removal of
the endothelium from rat aortic rings led to an increased
sensitivity to exogenous nitrovasodilators, at the level of solu-
ble guanylate cyclase. Therefore, in healthy animals in which
endothelial NO production is acutely abolished, there is a
supersensitivity to nitrates in smooth muscle cells, similar to
that seen after denervation. In contrast, in cynomolgus mon-
keys with diet-induced atherosclerosis, the nitrovasodilator
response is not enhanced in the presence of endothelial
dysfunction (24). This response is probably much more analo-
gous to the complex situation in humans, where endothelial
dysfunction and atherosclerosis develop more slowly.
Limitations of the study. One limitation of the current
study is the use of a single, clinically utilized dose of NTG in all
subjects. We administered a pharmacologic dose of NTG
(400 mg sublingually) that elicits maximal dilation and is on the
plateau of the dose–response curve for human arteries (25–
27). Therefore we examined the maximal dilator response
achievable using this nitrovasodilator rather than a formal
dose–response curve. In addition, we studied only those vol-
unteers approached and willing to consent to studies on the
effects of risk factors on arterial physiology, and some selection
bias may therefore be present. Nevertheless, our subjects
represented a community-based sample, studied noninvasively,
with a wide range of age, cholesterol and blood pressure levels
and smoking histories, which includes the average population
values. Furthermore, the current results still support the
previous findings by our group (8,10,11) and others (1,5,9) that
endothelial dysfunction is an important early event in athero-
genesis in vivo in humans. The present large series only serves
to highlight a more subtle smooth muscle dysfunction, evi-
denced by an impaired dilator response to NTG that is
observed independently of the reduction in EDD. Given the
subtle nature of the smooth muscle defect, it is unlikely that
this defect would significantly influence measurements of EDD.
Although the vasodilator response to NTG may be im-
paired in the presence of atherosclerosis, exogenous nitrates
have been used successfully for the treatment of angina
pectoris for .100 years, and sublingual NTG remains the most
frequently used short-acting vasodilator in the therapy of
patients with symptomatic coronary artery disease (21). How-
ever, a greater understanding of the factors that modulate the
vasorelaxant response to NTG may lead to improvements in
achieving maximal arterial dilation at the sites of flow-limiting
stenoses.
Conclusions. We observed that the vasodilator response to
NTG is impaired in the brachial artery of asymptomatic
subjects with risk factors for coronary artery disease. This
finding is consistent with an abnormality in smooth muscle
function in adults at risk for atherosclerosis.
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